Author:
Müller-Ladner U.,Zgouras D.,Lindhoff-Last E.
Publisher
Springer Berlin Heidelberg
Reference70 articles.
1. Adu D, Pall A, Luqmani RA et al. (1997) Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Quarterly Medical Journal 90: 401–409
2. Ahmed MS, Wong CF 2007) Should rituximab be the rescue therapy for refractory mixed cryglobulinemia associated with hepatitis C. J Nephrol 20: 350–356
3. Aktulga A, Altaüftrüoglu A et al. (1980) A double blind study of colchizine in Behçet’s disase. Haematologica 65: 399–402
4. Amoura Z, Choukroun G, Royer I et al. (1990) Treatment of systemic diseases with pulse cyclophosphamide: 15 cases. Ann Med Int 141: 416–420
5. Aries PM, Lamprecht P, Gross WL (2007) Biological therapies: new treatment options for ANCA-associated vasculitis. Expert Opin Biol Ther 7: 521–533